Although HERC4 is oncogenically overexpressed in several cancers including lung cancer and breast cancer, it is downregulated during the progress of myelomagenesis from health bone marrow, MGUS, SMM to typical MM (11, 26). The gene discussed is HERC4; the disease is breast carcinoma.